Latest hematologic neoplasms Stories
Data presented at the American Society for Blood and Marrow Transplantation's 2015 BMT Tandem Meeting SUNNYVALE, Calif., Feb. 17, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
DUBLIN, Feb .04, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/hp66c6/hematological)
SALT LAKE CITY, Jan.
WHITE PLAINS, N.Y., Jan. 29, 2015 /PRNewswire-USNewswire/ -- Today's U.S.
New IMBRUVICA Data from National Institutes of Health Study Published in The Lancet Oncology SUNNYVALE, Calif., Jan. 5, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO, Dec.
IMBRUVICA data presented at the American Society of Hematology Annual Meeting show 79 percent of CLL patients with del 17p were progression-free at 12 months SAN FRANCISCO and RARITAN, N.J.,
Data Show 84% Progression-Free Survival Rate at One Year and Improvement in Quality of Life SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
Maximum tolerated dose (MTD) identified and expansion cohort open to enrollment; Minimal Response (MR) or better has been observed in 25% of 8 patients treated to date at the MTD or higher
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.